Disease Progression for Histologic Diagnosis of Metabolic Dysfunction-Associated Steatotic Liver Disease in the Real-World: A Nationwide US Study
These data can inform clinical patient management that biopsy patients likely represent a selected group at higher risk for disease progression, especially in clinical trials for MASLD therapies.
Authors
- Ramsey Cheung (ORCID: https://orcid.org/0000-0002-0211-7013)
- Leslie Y. Kam (ORCID: https://orcid.org/0000-0002-0469-4543)
- Mindie H. Nguyen (ORCID: https://orcid.org/0000-0002-6275-4989)
- Scott D. Barnett (ORCID: https://orcid.org/0000-0002-4690-3278)
- Linda Henry (ORCID: https://orcid.org/0000-0002-7833-6124)
- Xinrong Zhang (ORCID: https://orcid.org/0000-0002-8393-8904)
Institutions
- Palo Alto University (US)
- VA Palo Alto Health Care System (US)
- Stanford Medicine (US)
- Stanford University (US)
Publication Details
- Journal
- Digestive Diseases
- Published
- 2024-10-14
- DOI
- https://doi.org/10.1159/000541945
- Citations
- 2
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.77